Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anita L. Dharan"'
Autor:
Anita L. Dharan, Stephen C. Bowden, Alan Lai, Andre D.H. Peterson, Mike W.-L. Cheung, Wessel Woldman, Wendyl J. D'Souza
Publikováno v:
Data in Brief, Vol 39, Iss , Pp 107665- (2021)
This article describes source data from a systematic review and meta-analysis of electroencephalography (EEG) and magnetoencephalography (MEG) studies investigating functional connectivity in idiopathic generalized epilepsy. Data selection, analysis
Externí odkaz:
https://doaj.org/article/5dee392b406548b9842542822a41a63d
Autor:
Anita L. Dharan, Stephen C. Bowden, Andre Peterson, Alan Lai, Udaya Seneviratne, Gabriel Dabscheck, Ewan Nurse, Amy Loughman, Nicholas Parsons, Wendyl J. D'Souza
Publikováno v:
Epilepsia. 64:742-753
Autor:
Andre D. H. Peterson, Wessel Woldman, Wendyl D'Souza, Mike W.-L. Cheung, Alan Lai, Stephen C. Bowden, Anita L. Dharan
Publikováno v:
Epilepsybehavior : EB. 124
For idiopathic generalized epilepsies (IGE), brain network analysis is emerging as a biomarker for potential use in clinical care. To determine whether people with IGE show alterations in resting-state brain connectivity compared to healthy controls,
Autor:
Richard A A Kanaan, Alice Maier, Michael Berk, Gina Oliver, Sudie E. Back, Chee H. Ng, Peter W. Kalivas, Anita L. Dharan, Suzy Redston
Publikováno v:
BMC Psychiatry
BMC Psychiatry, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Psychiatry, Vol 20, Iss 1, Pp 1-9 (2020)
Background Most patients with Posttraumatic Stress Disorder (PTSD) suffer residual symptoms following first-line treatment. Oxidative stress has been implicated in the pathophysiology of PTSD. N-acetylcysteine (NAC) is a precursor of the brain’s pr
Autor:
Graham Hepworth, Sophia Ignatiadis, Mark J. Cook, Johanna Sofia Moraes, Wendyl D'Souza, Udaya Seneviratne, Ross Carne, Anita L. Dharan
Publikováno v:
Epilepsy & Behavior. 104:106883
Objective The objective of this study was to evaluate the efficacy and tolerability of perampanel (PER) in late adjunctive treatment of focal epilepsy. We assessed outcomes 1) according to patients' clinical profiles and the broad mechanism of action